Hansens disease primarily affects the skin, nerves, and mucous membranes, leading to characteristic skin lesions and nerve damage. Hansen's disease has a long incubation period, often taking years or even decades for symptoms to manifest, which complicates early diagnosis and treatment. Despite being curable with multidrug therapy, social stigma and misconceptions surrounding the disease persist, leading to discrimination and marginalization of affected individuals. Efforts to eliminate Hansen's disease as a public health threat continue, focusing on early detection, prompt treatment, and destigmatization to ensure affected individuals receive the care and support they need.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Detection and variant characterization of lumpy skin disease virus (LSDV) from dairy cattle in India
Manali Bajpai, CSIR-National Chemical Laboratory, India
Title : Acceptability of mass drug administration for lymphatic filariasis in Baglung municipality of Nepal: A mixed-method study
Muskan Pudasainee, Pokhara University, Nepal